IRIS

Sfoglia per Rivista  CANCER RESEARCH

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 19 di 19
Titolo Data di pubblicazione Autore(i) File
A six-gene signature predicting breast cancer lung metastasis 1-gen-2008 Landemaine, T; Jackson, A; Bellahcene, A; Rucci, Nadia; Sin, S; Abad, Bm; Sierra, A; Boudinet, A; Guinebretiere, Jm; Ricevuto, Enrico; Nogues, C; Briffod, M; Bieche, I; Cherel, P; Garcia, T; Castronovo, V; Teti, ANNA MARIA; Lidereau, R; Driouch, K.
Alterations of choline phospholipid metabolism in ovarian tumor progression 1-gen-2005 Iorio, E; Mezzanzanica, D; Alberti, P; Spadaro, F; Ramoni, C; D'Ascenzo, S; Millimaggi, D; Pavan, A; Dolo, Vincenza; Canevari, S; Podo, F.
BASEMENT-MEMBRANE TYPE-IV COLLAGEN DEGRADATION - EVIDENCE FOR THE INVOLVEMENT OF A PROTEOLYTIC CASCADE INDEPENDENT OF METALLOPROTEINASES 1-gen-1990 Mackay, ANDREW REAY; Corbitt, Rh; Hartzler, Jl; Thorgeirsson, Up
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. 1-gen-1986 Gulino, A; Barrera, G; Vacca, A; Farina, Antonietta; Ferretti, C; Screpanti, I; Dianzani, Mu; Frati, L.
Estrogen receptor-β affects the prognosis of human malignant mesothelioma 1-gen-2009 Pinton, G.; Brunelli, E.; Murer, B.; Puntoni, R.; Puntoni, M.; Fennell, D. A.; Gaudino, G.; Mutti, L.; Moro, L.
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma 1-gen-2002 Lovat, Pe; Oliverio, S; Ranalli, M; Corazzari, M; Rodolfo, C; Bernassola, F; Aughton, K; Maccarrone, M; Hewson, Qdc; Pearson, Adj; Melino, G; Piacentini, M; Redfern, Cpf
GADD45β loss ablates innate immunosuppression in cancer 1-gen-2018 Verzella, Daniela; Bennett, Jason; Fischietti, Mariafausta; Thotakura, Anil Kumar; Recordati, Camilla; Pasqualini, Fabio; Capece, Daria; Vecchiotti, Davide; D'Andrea, Daniel; Di Francesco, Barbara; De Maglie, Marcella; Begalli, Federica; Tornatore, Laura; Papa, Salvatore; Lawrence, Toby; Forbes, Stuart; Sica, Antonio; Alesse, Edoardo; Zazzeroni, Francesca; Franzoso, Guido
Glucocorticoid-binding components in human thymus hyperplasia 1-gen-1978 Carmignani, Marco; Ranelletti, F. O.; Iacobelli, S.; Tonali, C.
Glucorticoid receptors and in vitro corticosensitivity in human thymoma 1-gen-1980 Carmignani, Marco; Ranelletti, F. O.; Iacobelli, S.; Sica, G.; Natoli, C.; Tonali, P.
High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma 1-gen-2002 Bolognesi, C.; Filiberti, R.; Neri, M.; Perrone, E.; Landini, E.; Canessa, P. A.; Simonassi, C.; Cerrano, P. G.; Mutti, L.; Puntoni, R.
Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study. 1-gen-2013 Recchia, F; Candeloro, G; Cesta, A; Di Blasio, A; Recchia, Coc; Necozione, Stefano; Desideri, Giovambattista; Rea, S.
Mass spectrometry driven discovery proteomics of serum from mice with human ovarian cancer resulted in identification of a potential cancer-origin biomarker that correlates with peritoneal tumor burden. 1-gen-2009 Wei, B; Hoover, Sb; Spehalski, E; Zhou, W; Edwards, Jb; Tessitore, Alessandra; Ross, Mm; Risinger, Ji; Goldsmith, Pk; Alvord, Wg; Quinones, O; Woolard, Kd; Liotta, La; Petricoin, Ef; Simpson, Rm
Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells 1-gen-2008 Spadaro, F; Ramoni, C; Mezzanzanica, D; Miotti, S; Alberti, P; Cecchetti, S; Iorio, E; Dolo, Vincenza; Canevari, S; Podo, F.
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 1-gen-2010 Rucci, Nadia; Millimaggi, D; Mari, M; Del Fattore, A; Bologna, Mauro; Teti, ANNA MARIA; Angelucci, Adriano; Dolo, Vincenza
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells 1-gen-1998 Dolo, Vincenza; Ginestra, A; Cassara, D; Violini, S; Lucania, G; Torrisi, Mr; Nagase, H; Canevari, S; Pavan, A; Vittorelli, M. L.
SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: A molecular epidemiologic case-control study 1-gen-2005 Cristaudo, A.; Foddis, R.; Vivaldi, A.; Buselli, R.; Gattini, V.; Guglielmi, G.; Cosentino, F.; Ottenga, F.; Ciancia, E.; Libener, R.; Filiberti, R.; Neri, M.; Betta, P.; Tognon, M.; Mutti, L.; Puntoni, R.
SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure 1-gen-2005 Cacciotti, P.; Barbone, D.; Porta, C.; Altomare, D. A.; Testa, J. R.; Mutti, L.; Gaudino, G.
Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 CIA31-1-1 cell line 1-gen-1984 Bignami, M; Ficorella, Corrado; Dogliotti, E; Norman, Rl; Kaighn, Me; Saffiotti, U.
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 1-gen-1998 Farina, Ar; Tacconelli, A; Teti, ANNA MARIA; Gulino, A; Mackay, ANDREW REAY
Mostrati risultati da 1 a 19 di 19
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile